Join Phunware to explore how connected health will create new opportunities for engaging with patients before, during and after hospital visits.
Value is a concept that concerns all healthcare stakeholders.
About 80% of polled dermatologists told Leerink Partners they would likely prescribe the experimental biologic dupilumab.
Spurred by consolidation, the life sciences industry spent more money on acquisitions in the first quarter than it did in all of 2014 combined.
AbbVie expected to submit chronic lymphocytic leukemia drug venetoclax to the FDA this year.
The company partnered with AstraZeneca and BioMarin to identify which patients respond to experimental cancer drugs.
Amgen raises price of Enbrel by 10%; pharma companies appear to raise diabetes drug prices in tandem; Alexion agrees to buy rare-disease drugmaker for $8.4 billion
A study found that cost-effectiveness and clinical-effectiveness measures often point to the same treatment protocol.
Hernandez is known for his ability to bring together patients and pharma. He joined Livongo Health to aid the firm's user experience.
Worldwide spending on cancer medications hit $100 billion last year; Bayer adds an anticoagulant to its pipeline for $100 million; GlaxoSmithKline has a new chairman
Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.